Novo Nordisk reported mostly mild side effects from its experimental weight-loss drug CagriSema, though results upset ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s compe ...

How Australian pregnant women are tested for gestational diabetes is set to change, with new national guidelines released ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Fred Kocher sits down with Lilly Wellington, Executive Director of the New Hampshire Commission On Aging, and Jennifer ...

Zeus and Lilly Bell are both 10-year-old male and female Labrador Retriever Pit Bull Terrier mix dogs, weighing approximately ...

In the fog of jurisdictional war, the legal battle between Donald Trump & Gavin Newsom over troops on the ground the streets ...

The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with placebo in patients with overweight or obesity with or without ...

The U.S. Department of Agriculture considers vaccinating poultry against bird flu amidst a major animal-health crisis, with ...

Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...

Tony Gomes of Modesto made a race day decision to compete and stormed for his first career Ocean Sprints victory on Friday ...